Hattie WebsterEsta cuenta se ha cancelado
Hattie Webster
|
 |
This tramadol order survey addressed the overall population in the form of a representative sample focusing on subjects who indicated, at the time they were consulted, that they were taking an antidepressant. drospirenone & ethinyl estradiol The two products most widely prescribed in that class were Fluoxetine ( Prozac ) (30% of the subjects taking an antidepressant at time t) and Paroxetine ( Paxil ) (10% of the subjects taking an antidepressant at time t). Results - Out of 20 000 households, comprising 44 000 people aged over 15 years, 1 333 people were taking an antidepressant drospirenone & ethinyl estradiol or had taken one in the previous 4 weeks. Somatic comorbidity was present in 60% of antidepressant consumers. Longitudinal follow-up over 8 months from the initial screening was evaluated using a monthly questionnaire on the time course of antidepressant consumption. Among the people receiving antidepressants, 54% had a CIDI diagnosis in strict compliance with the marketing One quarter (25%) presented with a diagnosis of a characterized psychiatric disease, outside of the marketing This ilosone finding reflects misuse or use on the basis of published data not incorporated in the buy fioricet marketing The dosages were in line with those stated in the marketing Tricyclic antidepressants would therefore appear to be frequently inappropriately in terms of proportions that would be ineffective. cyclosporine eye drops Only 4% of the patients were concomitantly taking 2 antidepressants. Prescriber file, reason for prescription, type of medication prescribed, match between the prescription and the product indications stated in the marketing Methodology - The first stage consisted in forwarding a letter to a panel of 44 antidepressant medications 000 subjects aged 15 years or more and representative of the French population. Sixty-two percent of subjects presented with, or had presented with, a mood disorder as per M-CIDI (major depression, mood disorder, or a combination of the two) and 14% an isolated anxiety disorder. In France, in a week, the prevalence of antidepressant use in the overall population generic ilosone increased from 1.7% in 1992 to 3% in 1995. The main reason for prescription reported by the patient was depression (57% of cases); follo by a state of anxiety or stress (15% of cases). Women consume more antidepressants than men. Lifestyle and socioprofessional ilosone category did not seem to influence antidepressant consumption. The study aimed to determine the circumstances of prescription. The mean age of the subjects taking an antidepressant at time t was 51 years. The aim was to achieve a cross-sectional description of the population taking antidepressants. The sex ratio of the antidepressant consumers was 3 women to 1 man, amplifying the known sex ratio with respect to depressive disorders. For 60% of the subjects, the antidepressant treatment was prescribed by a general practitioner. Clomipramine in 16% of cases, Amitriptyline ( Elavil ) in 14%, and other tricyclic antidepressants in 9%. Twenty-five percent of the subjects on antidepressants did not fulfill all the M-CIDI criteria for any diagnosis. The other SSRIs accounted for the remaining 5%. Conclusion - This survey shows that the point-prevalence of antidepressants in the global population in France is about 3.5%. Single-agent therapy is in line with the recommendations of the various expert groups. SSRIs are the most widely prescribed antidepressants. General practitioners prescribe less tricyclic antidepressants and more SSRIs than specialists. Half of the subjects on clomipramine were taking a dose less than or equal to one third of the minimum recommended dose. Antidepressants consumption in the global population in FranceThe consumption of antidepressant seems to be in France higher than in comparable countries, as well as the overall consumption of healthcare and medications. In the survey, 9 antidepressant prescriptions out of 10 were written by an open-care practitioner, and 1 out of 10 by a hospital physician. The survey findings point out the discrepancies between official indications, such as the ones issued by the regulatory authorities, and the physicians' prescribing practices.. Among the consumers of antidepressants at time t, 45% were taking a selective serotonin reuptake inhibitor (SSRI). The response rate was 82% (36 036 subjects). Lastly, 20% of the consumers were taking an antidepressant that was neither an SSRI nor a tricyclic antidepressant. In 10% of cases, the consumer stated that the reason for treatment was not psychological. The subjects who stated that they were taking an antidepressant were re-contacted by telephone by an interviewer trained in the use of the Composite International Diagnostic Interview - lifetime (CIDI), exploring depression and anxiety diseases with a view to potential diagnosis as per DSM criteria. Thirty-nine percent of the consumers were taking a tricyclic antidepressant. In Western countries, in recent years, the use of antidepressants has regularly increased, mainly due to the use of serotoninergic antidepressants.
|
|
CursosFormacion.net |
|
|
Calle San Miguel, 25 29780 Nerja |
|
| Tel/Fax: +34 95 252 37 88 info@cursosformacion.net |
|
Usted no se ha autentificado. (Entrar)
|